These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 5823955

  • 1. Reduction in the frequency of mutation to resistance to cytarabine in L1210 murine leukemic cells by treatment with quinacrine hydrochloride.
    Bach MK.
    Cancer Res; 1969 Oct; 29(10):1881-5. PubMed ID: 5823955
    [No Abstract] [Full Text] [Related]

  • 2. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
    Kline I, Venditti JM, Tyrer DD, Goldin A.
    Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.
    Kline I, Venditti JM, Tyrer DD, Mantel N, Goldin A.
    Cancer Res; 1966 Sep; 26(9):1930-7. PubMed ID: 5924958
    [No Abstract] [Full Text] [Related]

  • 5. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
    Rose WC, Trader MW, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
    [No Abstract] [Full Text] [Related]

  • 6. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD, Kline I, Venditti JM, Goldin A.
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract] [Full Text] [Related]

  • 7. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD, Grindey GB, Kline I, Waravdekar VS.
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract] [Full Text] [Related]

  • 8. Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.
    Baldini L, Brambilla G, Cavanna M, Parodi S.
    Br J Pharmacol; 1968 Nov; 34(3):674P-676P. PubMed ID: 5726804
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A.
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract] [Full Text] [Related]

  • 10. Active immunotherapy in spontaneous leukemia of AkR mice.
    Mathé G, Halle-Pannenko O, Bourut C.
    Exp Hematol; 1973 Apr; 1(2):110-4. PubMed ID: 4609352
    [No Abstract] [Full Text] [Related]

  • 11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.
    Neil GL, Wiley PF, Manak RC, Moxley TE.
    Cancer Res; 1970 Apr; 30(4):1047-54. PubMed ID: 5504347
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Criteria associated with destruction of leukemia and solid tumor cells in animals.
    Skipper HE.
    Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone.
    Grindey GB, Mihich E, Nichol CA.
    Cancer Res; 1972 Mar; 32(3):522-6. PubMed ID: 5061306
    [No Abstract] [Full Text] [Related]

  • 17. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC, Schmid FA, Feinberg A, Philips FS, Han J.
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [Abstract] [Full Text] [Related]

  • 18. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
    Mihich E, Mulhern AI.
    Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
    [No Abstract] [Full Text] [Related]

  • 19. [Chronobiological aspects of experimental leukemia].
    Ratte J, Haus E, Halberg F, Kühl JF, Shiotsuka R, Najarian JS.
    Union Med Can; 1974 Jul; 103(7):1201-7. PubMed ID: 4842174
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.